Clinical Trials on Recurrent Intraocular Melanoma
Total 9719 results
-
Lytix Biopharma ASLaboratory Corporation of America; OWLActive, not recruitingAdvanced MelanomaUnited States, Spain, France, Norway
-
BiocadActive, not recruitingClinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced MelanomaMelanoma (Skin)Russian Federation
-
Centre Hospitalier Universitaire de NiceCompletedMetastatic MelanomaFrance
-
Abramson Cancer Center at Penn MedicineImaginAb, Inc.Enrolling by invitation
-
Suthee RapisuwonBristol-Myers SquibbActive, not recruitingMelanoma | Ocular MelanomaUnited States
-
Novartis PharmaceuticalsCompleted
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCutaneous MelanomaUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedMetastatic MelanomaFrance
-
Ludwig Institute for Cancer ResearchBristol-Myers SquibbTerminatedMetastatic MelanomaAustralia
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMelanoma (Skin)United States
-
Regeneron PharmaceuticalsCompleted
-
Yale UniversityTerminatedMetastatic MelanomaUnited States
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Aarhus University HospitalCompletedMalignant MelanomaDenmark
-
Emory UniversityWithdrawn
-
Prof. Dr. med. Dirk SchadendorfCompletedMalignant MelanomaGermany
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); University of Southern California; University... and other collaboratorsCompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminatedMetastatic MelanomaUnited States
-
The Christie NHS Foundation TrustCancer Research UK; Christie Charitable FundsCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbWithdrawn
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
Prof. Dr. med. Dirk SchadendorfCompleted
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Timmune Biotech Inc.The Second Affiliated Hospital of Hainan Medical University; Hainan Cancer...Unknown
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Peking University Cancer Hospital & InstituteUnknown
-
VicalCompletedMetastatic MelanomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompleted
-
Hadassah Medical OrganizationUnknown
-
Centre Hospitalier Universitaire VaudoisCompletedOcular MelanomaSwitzerland
-
Western Regional Medical CenterTerminated
-
Inge Marie SvaneCopenhagen University Hospital at HerlevTerminated
-
Peking University Cancer Hospital & InstituteKiang Wu HospitalUnknown
-
NYU Langone HealthTerminatedMetastatic MelanomaUnited States
-
Sun Yat-sen UniversityUnknown
-
American Regent, Inc.CompletedMalignant MelanomaUnited States
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLCUnknownMetastatic MelanomaNetherlands
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
Hospices Civils de LyonUnknown
-
Scancell LtdTerminated
-
Hoffmann-La RocheCompleted
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Genentech, Inc.Terminated
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompleted